The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Samuel Goldlust, MD
Hackensack University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lalita Pandit
Fountain Valley, California, United States
- Robert Moss
Fountain Valley, California, United States
- Alliance Research Centers
Laguna Hills, California, United States
- Global Research Management
Los Angeles, California, United States
- Innovative Clinical Research
Los Angeles, California, United States
- El Camino Cancer Center
Mountain View, California, United States
- Pacific Cancer Care
Salinas, California, United States
- Redwood Regional Medical Group
Santa Rosa, California, United States
- St. Vincent'S Medical Center
Bridgeport, Connecticut, United States
- Medsol Clinical Research Center
Port Charlotte, Florida, United States
- Axcess Medical Research
Wellington, Florida, United States
- Cancer Center of Middle Georgia
Dublin, Georgia, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- St. Louis Cancer Care
Bridgeton, Missouri, United States
- Mercy Medical Research Institute
Springfield, Missouri, United States
- John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
- New Mexico Oncology Hematology Consultants
Albuquerque, New Mexico, United States
- Signal Point Clinical Research Center
Middletown, Ohio, United States
- Institute of Pain Research
Oklahoma City, Oklahoma, United States
- Gettysburg Cancer Center
Gettysburg, Pennsylvania, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Jean Brown Research
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2012
- Primary completion
- 31 Jan 2015
- Completion
- 11 Feb 2015
- Last update posted
- 30 Oct 2018
- Registered enrollment
- 125
- Registry id
- NCT01655823
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.